High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis, New England Journal of Medicine, vol.357, issue.11, pp.1083-93, 2007. ,
DOI : 10.1056/NEJMoa070484
URL : https://hal.archives-ouvertes.fr/hal-00172895
High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant, Bone Marrow Transplantation, vol.24, issue.8, pp.853-858, 1999. ,
DOI : 10.1038/sj.bmt.1702005
Stem cell transplantation for the management of primary systemic amyloidosis, The American Journal of Medicine, vol.113, issue.7, pp.549-55, 2002. ,
DOI : 10.1016/S0002-9343(02)01208-1
Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis, Bone Marrow Transplantation, vol.35, issue.4, pp.419-439, 2005. ,
DOI : 10.1038/sj.bmt.1704772
Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis???, European Journal of Cardio-Thoracic Surgery, vol.33, issue.2, pp.257-62, 2008. ,
DOI : 10.1016/j.ejcts.2007.10.025
Cardiac Transplantation Using Extended-Donor Criteria Organs for Systemic Amyloidosis Complicated by Heart Failure, Transplantation, vol.83, issue.5, pp.539-584, 2007. ,
DOI : 10.1097/01.tp.0000255567.80203.bd
Living Donor Kidney and Autologous Stem Cell Transplantation for Primary Systemic Amyloidosis (AL) with Predominant Renal Involvement, American Journal of Transplantation, vol.12, issue.7, pp.1660-70, 2005. ,
DOI : 10.1038/nm0798-775
Quantitative Analysis of Serum Free Light Chains, American Journal of Clinical Pathology, vol.119, issue.2, pp.274-282, 2003. ,
DOI : 10.1309/LYWM47K2L8XYFFB3
Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains, Clin Chem, vol.48, issue.9, pp.1437-1481, 2002. ,
Perspectives in treatment of AL amyloidosis, British Journal of Haematology, vol.108, issue.1, pp.365-77, 2008. ,
DOI : 10.1046/j.1365-2141.1999.01136.x
Long term results of heart transplantation in patients with amyloid heart disease, Heart, vol.85, issue.2, pp.202-209, 2001. ,
DOI : 10.1136/heart.85.2.202
Heart transplantation in patients with amyloidosis: single-center experience, Transplantation Proceedings, vol.36, issue.3, pp.643-647, 2004. ,
DOI : 10.1016/j.transproceed.2004.03.077
Cardiac transplantation for amyloid heart disease: The United Kingdom experience, The Journal of Heart and Lung Transplantation, vol.23, issue.10, pp.1142-53, 2004. ,
DOI : 10.1016/j.healun.2003.08.027
Outcome of Heart Transplantation in Patients With Amyloid Cardiomyopathy, The Journal of Heart and Lung Transplantation, vol.24, issue.11, pp.1763-1768, 2005. ,
DOI : 10.1016/j.healun.2004.08.025
Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis, Haematologica, vol.93, issue.3, pp.32-37, 2008. ,
DOI : 10.3324/haematol.12108
URL : https://hal.archives-ouvertes.fr/hal-00452947
The role of renal transplantationin systemic AL amyloidosis, Blood, vol.106, p.3497 ,